Dexamethasone Added in Ultrasound-guided Transversus Abdominis Plain Block for Postoperative Analgesia
Postoperative Pain
About this trial
This is an interventional prevention trial for Postoperative Pain focused on measuring Analgesia, Dexamethasone, Levobupivacaine, Ultrasound-guided, Tranversus Abdominis
Eligibility Criteria
Inclusion Criteria:
- Patients with ASA score I and II
- age 18 years
Exclusion Criteria:
- Allergy to local anesthetics
- Allergy to general anesthetics
- Allergy or intolerance to acetaminophen
- Severe renal impairment
- Severe hepatic impairment
- Congestive heart failure
- Coagulation disorders
- hypoprotidemia
- Diabetes mellitus History
- Age greater than 70 years
- Age below 18 years
- ASA Physical than 3 Status
- Lack of informed consent
- Patients unable to discernment
- Intolerance to opiates
- Peptic Ulcer
- Abuse of alcohol and / or drugs
Sites / Locations
- Emiliano Petrucci
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Placebo Comparator
Active Comparator
TAP Block and Dexamethasone
TAP Block and Saline
TAP Block and Dexamethasone i.v.
After general anesthesia and before the beginning of surgery, 4 mg of Dexamethasone are added to 20 ml of 0,375% Levobupivacaine in Ultrasound-guided Tranversus Abdominis Plain Block.
After general anesthesia and before the beginning of surgery, 2 ml of saline are added to 20 ml of 0.375% Levobupivacaine in Ultrasound-guided Tranversus Abdominis Plain Block.
After general anesthesia and before the beginning of surgery, 20 ml of 0,375% Levobupivacaine are used in Ultrasound-guided Tranversus Abdominis Plain Block. In this group 4 mg of dexamethasone are injected intravenously.